870 filings
Page 15 of 44
8-K
DRRX
Durect Corp
19 Nov 18
Other Events
8:30am
10-Q
2018 Q3
DRRX
Durect Corp
Quarterly report
8 Nov 18
5:02pm
8-K
DRRX
Durect Corp
7 Nov 18
DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update
12:00am
8-K
DRRX
Durect Corp
5 Nov 18
Entry into a Material Definitive Agreement
9:00am
8-K
DRRX
Durect Corp
25 Oct 18
DURECT Announces Abstracts on DUR-928 to be Presented at Upcoming Scientific Meetings
8:30am
3
DRRX
Durect Corp
24 Oct 18
DURECT / Michael Arenberg ownership change
8:57pm
3
Michael Arenberg
24 Oct 18
DURECT / Michael Arenberg ownership change
8:55pm
4
Michael Arenberg
17 Oct 18
DURECT / Michael Arenberg ownership change
8:43pm
424B2
DRRX
Durect Corp
10 Oct 18
Prospectus for primary offering
4:17pm
EFFECT
DRRX
Durect Corp
10 Oct 18
Notice of effectiveness
12:15am
CORRESP
DRRX
Durect Corp
5 Oct 18
Correspondence with SEC
12:00am
8-K
DRRX
Durect Corp
1 Oct 18
DURECT Corporation Appoints Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer
4:31pm
S-3/A
DRRX
Durect Corp
Shelf registration (amended)
28 Sep 18
5:19pm
CORRESP
DRRX
Durect Corp
28 Sep 18
Correspondence with SEC
12:00am
8-K
DRRX
Durect Corp
21 Sep 18
Entry into a Material Definitive Agreement
8:30am
UPLOAD
DRRX
Durect Corp
21 Sep 18
Letter from SEC
12:00am
8-K
DRRX
Durect Corp
18 Sep 18
DURECT Announces Methydur Sustained Release Capsules Receive Marketing Authorization for ADHD in Taiwan
12:00am
S-3/A
DRRX
Durect Corp
Shelf registration (amended)
12 Sep 18
12:00am
CORRESP
DRRX
Durect Corp
12 Sep 18
Correspondence with SEC
12:00am
CT ORDER
DRRX
Durect Corp
4 Sep 18
Confidential treatment order
12:00am